The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours

Veterinary and Comparative Oncology

Volumn 7, Issue 4, 2009, Pages 230-235

  Ferreira, E ^a   Bertagnolli, A C ^a   Cavalcanti, M F ^a   Schmitt, F C ^b   Cassali, G D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Dog; Immunohistochemical; Mammary tumour; Survival time; Tumour size

Indexed keywords

TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DOG DISEASES; DOGS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 70450060533     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2009.00193.x     Document Type: Article

References (28)

1. Meuten DJ. Tumors in Domestic Animals. 2002, 4th edn., Oxford, Wiley-Blackwell
2. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement, 1999. Archives of Pathology & Laboratory Medicine 2000, 124:966-978.
3. Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, Conti R, Lellis R, Vincenso DD, Patrizia P, Virgilio S, Clemente C, Salvadori B. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Annals of Surgery 1985, 202:702-707.
4. Peña LL, Nieto AI, Perez-Alenza D, Cuesta P, Castano M. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables. Journal of Veterinary Diagnostic Investigation 1998, 10:237-246.
5. Martín de Las Mulas J, Milia Y, Dios R. A prospective analysis of immunohistochemically determined estrogen receptor a and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Veterinary Pathology 2005, 42:200-212.
6. Zacchetti A, Van Garderen E, Rutteman GR. Immunohistochemical evaluation of p53 expression with different antibodies in malignant canine tumours with or without p53 gene mutation. Veterinary and Comparative Oncology 2007, 5:108-118.
7. Yamagami Y, Kpbayaschi T, Takahashi K, Sugiyama M. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. The Journal Veterinary Medical Science 1996, 58:1079-1083.
8. Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW, Waters DJ. Influence of host factors on survival in dogs with malignant mammary gland. Journal of Veterinary Internal Medicine 2003, 17:102-106.
9. De Nardi AB, Daleck CR, Souza CHM, Amorin RL, Rodaski S, Calderon C, Torres R. Cyclooxygenase-2 expression in mammary tumors in dogs and its correlation to histologic and biologic behavior. Veterinary and Comparative Oncology 2005, 3:56-57.
10. Bostock DE. The prognosis following the surgical excision of canine mammary neoplasms. European Journal of Cancer 1975, 11:389-396.
11. Misdorp W, Else W, Hellmén E, Lipscomb TP. Histological Classification of the Mammary Tumors of the Dog and the Cat 1999, Washington, DC, AFIP
12. Sannino P, Shousha S. Demonstration of oestrogen receptors in paraffin wax sections of breast carcinoma using the monoclonal antibody 1D5 and microwave oven processing. Journal of Clinical Pathology 1994, 47:90-92.
13. Dutra AP, Granja NV, Schmitt FC, Cassali GD. c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Brazilian Journal of Medical and Biological Research 2004, 37:1673-1681.
14. Castiglioni T, Elstner B, Curutchet HP, Montesinos M, Debonis D. Immunohistochemical analysis of p53 and c-erbB-2 in breast cancer. Medicina (B Aires) 1995, 55:415-420.
15. Schneider R, Dorn CR, Taylor DON. Factors influencing canine mammary cancer development and postsurgical survival. Journal of the National Cancer Institute 1969, 43:1249-1261.
16. D'arville CN, Pierrepoint CG. The demonstration of oestrogen, androgen, and progestagen receptors in cytosol fraction of canine mammary tumours. European Journal of Cancer 1979, 15:875-883.
17. Graham JC, Myers RK. The prognostic significance of angiogenesis in canine mammary tumors. Journal of Veterinary Internal Medicine 1999, 13:416-418.
18. Geraldes M, Gartner F, Schimitt F. An immunohistochemistry study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumours. The Veterinary Record 2000, 146:403-406.
19. Rutteman GR, Misdorp W, Blantenstein MA, Van den Brom WE. Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: different receptor profiles in non-malignant and malignant states. British Journal of Cancer 1988, 58:594-599.
20. Nieto A, Pérez-Alenza MD, Del Castillo N, Tabanera E, Castaño M, Peña L. Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Veterinary Pathology 2000, 37:239-247.
21. Sarli G, Preziosi R, Benazzi C, Castellani G, Marcato Ps. Prognostic value of histologic stage and proliferative activity in canine malignant mammary tumors. Journal of Veterinary Diagnostic Investigation 2002, 14:25-34.
22. Rungsipipat A, Tateyama S, Yamaguchi R, Uchida K, Miyoshi N, Hayashi T. Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. The Journal of Veterinary Medicine Science 1999, 6:27-32.
23. Sagartz JE, Bodley WL, Gamblin RM, Couto CG, Tierney LA, Capen CC. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Veterinary Pathology 1996, 33:213-221.
24. Bertagnolli AC, Cassali GD, Genelhu MCLS, Costa FA, Oliveira JFC, GonÇalves PBD. Immunohistochemical expression of p63 and Δ np63 in mixed tumors of canine mammary glands and its relation with p53 expression. Veterinary Pathology 2009, 46:407-415.
25. Hsu WL, Huang HM, Liao JW, Wong ML, Chang SC. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. The Veterinary Journal 2009, 180:116-123.
26. Martin de las Mulas J, Ordás J, Millán Y, Fernández-Soria V, Ramón y Cajal S. Oncogene HER-2 in canine mammary gland carcinomas: an immunohistochemical and chromogenic in situ hybridization study. Breast Cancer Research and Treatment 2003, 80:363-367.
27. Genelhu MC, Cardoso SV, Gobbi H, Cassali GD. A comparative study between mixed-type tumors from human salivary and canine mammary glands. BMC Cancer 2007, 7:218. (online)
28. Auclair PL, Ellis GL. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. Modern Pathology 1996, 9:652-657.